SCHEMBL16660367

SCHEMBL16660367

Cc1ccc(O)c(/C=N\CCNCCNCC/N=C\c2cc(C)ccc2O)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.53
KDM4E B2RXH2 4/20 0.53
HTT P42858 2/20 0.53
LMNA P02545 1/20 0.53
NPC1 O15118 4/20 0.49
RAB9A P51151 3/20 0.49
NFKB1 P19838 2/20 0.49
NFKB2 Q00653 2/20 0.49
RELA Q04206 2/20 0.49
GAA P10253 2/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.44
MEN1 O00255 1/20 0.44
POLB P06746 1/20 0.44
KMT2A Q03164 1/20 0.44
CASP3 P42574 1/20 0.44
SENP7 Q9BQF6 1/20 0.44
SENP6 Q9GZR1 1/20 0.44
CA2 P00918 6/20 0.43
CA12 O43570 5/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4353983 0.88 MAPT (0.61) MAPTKDM4EHTTLMNANPC1
SCHEMBL4353987 0.88 MAPT (0.61) MAPTKDM4EHTTLMNANPC1
SCHEMBL14354242 0.83 CA2 (0.59) MAPTKDM4EHTTLMNANPC1
SCHEMBL14354241 0.83 CA2 (0.59) MAPTKDM4EHTTLMNANPC1
SCHEMBL28243912 0.82 MAPT (0.54) MAPTKDM4EHTTLMNANPC1
SCHEMBL16660368 0.81 CA12 (0.47) MAPTKDM4EHTTLMNANPC1
SCHEMBL19393344 0.81 CA12 (0.71) MAPTKDM4EHTTLMNANPC1
SCHEMBL16657554 0.80 TYR (0.44) KDM4EHTTGAAKMT2ACA2
SCHEMBL10061910 0.79 MAPT (0.55) MAPTKDM4EHTTLMNANPC1
Acetic Acid SCHEMBL1229395 0.78 MAPT (0.50) MAPTKDM4EHTTLMNANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150110715-A1 Double-Labeled Probe for Molecular Imaging and Use Thereof RUPRECHT-KARLS-UNIVERSITAT HEIDELBERG (DE) 2015-04-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150110715-A1 Double-Labeled Probe for Molecular Imaging and Use Thereof CD47, ANXA5, CD44 MAPT 4045/4885KDM4E 2876/4885HTT 4466/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.